Efficacy and Safety of Conversion Therapy for pMMR/MSS T4M0 Colon Cancer Patients Treated With Radiotherapy and Systemic Therapy: a Prospective, Open-label, Multi-center, Randomized Controlled TrialNeo-Color
Latest Information Update: 09 Jul 2025
At a glance
- Drugs Iparomlimab/tuvonralimab (Primary) ; Capecitabine; Oxaliplatin
- Indications Adenocarcinoma; Colon cancer
- Focus Therapeutic Use
Most Recent Events
- 06 May 2025 New trial record